Fresenius SE Market Cap 2016-2025 | FSNUY

Fresenius SE market cap history and chart from 2016 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Fresenius SE market cap as of November 07, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $23.628B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.968B 18.58
Encompass Health (EHC) United States $11.598B 22.30
Elanco Animal Health (ELAN) United States $10.678B 22.39
DaVita (DVA) United States $8.733B 12.75
Chemed (CHE) United States $6.156B 21.62
RadNet (RDNT) United States $6.023B 217.53
Option Care Health (OPCH) United States $4.389B 18.68
LifeStance Health (LFST) United States $2.446B 0.00
Addus HomeCare (ADUS) United States $2.090B 21.58
Aveanna Healthcare Holdings (AVAH) United States $1.828B 23.03
Astrana Health (ASTH) United States $1.431B 134.39
U.S Physical Therapy (USPH) United States $1.123B 28.41
Atai Life Sciences (ATAI) Germany $1.019B 0.00
Pennant (PNTG) United States $0.884B 29.36
Daxor (DXR) United States $0.063B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.056B 0.00
Psychemedics (PMD) United States $0.000B 0.00